Thrivent Financial for Lutherans’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.48M | Sell |
34,853
-34,348
| -50% | -$2.35M | ﹤0.01% | 1293 |
|
|
2025
Q4 | $4.09M | Sell |
69,201
-15,488
| -18% | -$841K | 0.01% | 1033 |
|
|
2025
Q3 | $4.67M | Sell |
84,689
-1,050,711
| -93% | -$54.6M | 0.01% | 871 |
|
|
2025
Q2 | $48.9M | Sell |
1,135,400
-102,124
| -8% | -$3.94M | 0.11% | 227 |
|
|
2025
Q1 | $49M | Sell |
1,237,524
-10,923
| -0.9% | -$483K | 0.11% | 241 |
|
|
2024
Q4 | $50.9M | Sell |
1,248,447
-134,606
| -10% | -$5.61M | 0.1% | 269 |
|
|
2024
Q3 | $53.9M | Buy |
1,383,053
+23,497
| +2% | +$936K | 0.1% | 257 |
|
|
2024
Q2 | $59.4M | Buy |
1,359,556
+35,620
| +3% | +$1.72M | 0.12% | 220 |
|
|
2024
Q1 | $63.2M | Buy |
1,323,936
+26,805
| +2% | +$1.2M | 0.13% | 219 |
|
|
2023
Q4 | $61.3M | Buy |
1,297,131
+11,751
| +0.9% | +$488K | 0.13% | 220 |
|
|
2023
Q3 | $61.2M | Buy |
1,285,380
+25,480
| +2% | +$1.39M | 0.15% | 198 |
|
|
2023
Q2 | $73.3M | Buy |
1,259,900
+118,700
| +10% | +$7.12M | 0.17% | 174 |
|
|
2023
Q1 | $81.6M | Buy |
1,141,200
+108,397
| +10% | +$8.6M | 0.2% | 148 |
|
|
2022
Q4 | $72.8M | Buy |
1,032,803
+72,490
| +8% | +$5.11M | 0.19% | 151 |
|
|
2022
Q3 | $58.2M | Buy |
960,313
+46,994
| +5% | +$3.15M | 0.16% | 180 |
|
|
2022
Q2 | $57.7M | Buy |
913,319
+98,974
| +12% | +$6.45M | 0.15% | 181 |
|
|
2022
Q1 | $52.2M | Sell |
814,345
-78
| -0% | -$5.22K | 0.1% | 244 |
|
|
2021
Q4 | $58.4M | Buy |
814,423
+756,903
| +1,316% | +$57.6M | 0.11% | 228 |
|
|
2021
Q3 | $4.11M | Sell |
57,520
-474
| -0.8% | -$37.4K | 0.01% | 977 |
|
|
2021
Q2 | $4.72M | Sell |
57,994
-149
| -0.3% | -$12K | 0.01% | 951 |
|
|
2021
Q1 | $4.39M | Buy |
58,143
+5,742
| +11% | +$418K | 0.01% | 972 |
|
|
2020
Q4 | $3.97M | Sell |
52,401
-2,037
| -4% | -$133K | 0.01% | 950 |
|
|
2020
Q3 | $2.69M | Sell |
54,438
-3,380
| -6% | -$191K | 0.01% | 1011 |
|
|
2020
Q2 | $3.04M | Sell |
57,818
-14,040
| -20% | -$666K | 0.01% | 873 |
|
|
2020
Q1 | $2.53M | Hold |
71,858
| – | – | 0.01% | 849 |
|
|
2019
Q4 | $6.28M | Buy |
71,858
+60,990
| +561% | +$5.33M | 0.02% | 683 |
|
|
2019
Q3 | $922K | Sell |
10,868
-207
| -2% | -$18.4K | ﹤0.01% | 1460 |
|
|
2019
Q2 | $1.17M | Buy |
11,075
+322
| +3% | +$32.4K | ﹤0.01% | 1296 |
|
|
2019
Q1 | $1.14M | Sell |
10,753
-18,794
| -64% | -$1.89M | ﹤0.01% | 1290 |
|
|
2018
Q4 | $2.47M | Buy |
29,547
+883
| +3% | +$80K | 0.01% | 770 |
|
|
2018
Q3 | $2.92M | Sell |
28,664
-255
| -0.9% | -$24.6K | 0.01% | 770 |
|
|
2018
Q2 | $2.34M | Buy |
28,919
+618
| +2% | +$49.1K | 0.01% | 851 |
|
|
2018
Q1 | $2.09M | Buy |
28,301
+2,033
| +8% | +$152K | 0.01% | 877 |
|
|
2017
Q4 | $1.85M | Buy |
26,268
+203
| +0.8% | +$14.6K | 0.01% | 943 |
|
|
2017
Q3 | $1.63M | Buy |
26,065
+725
| +3% | +$42.9K | 0.01% | 940 |
|
|
2017
Q2 | $1.46M | Buy |
25,340
+1,730
| +7% | +$102K | 0.01% | 939 |
|
|
2017
Q1 | $1.44M | Sell |
23,610
-16,057
| -40% | -$908K | 0.01% | 981 |
|
|
2016
Q4 | $2.18M | Sell |
39,667
-18,730
| -32% | -$898K | 0.01% | 828 |
|
|
2016
Q3 | $2.69M | Buy |
58,397
+990
| +2% | +$41.8K | 0.01% | 779 |
|
|
2016
Q2 | $1.96M | Buy |
+57,407
| New | +$1.79M | 0.01% | 872 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Thrivent Financial for Lutherans's NGVT Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Ingevity (NGVT) stake by 50% in Q1 2026, selling an estimated $2.35M and leaving 34,853 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1293.
Thrivent Financial for Lutherans first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $81.6M in Q1 2023. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Thrivent Financial for Lutherans held 34,853 shares of Ingevity worth $2.48M as of Q1 2026.
- Thrivent Financial for Lutherans sold 34,348 Ingevity shares in Q1 2026, an estimated $2.35M.
- Ingevity made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1293 holding.
- Thrivent Financial for Lutherans first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
- Thrivent Financial for Lutherans's Ingevity position peaked at $81.6M in Q1 2023.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.